Santosh Kumar Yadav: PF4 Emerges as a Central Player in Antiphospholipid Syndrome
Santosh Kumar Yadav, Associate Scientist at Children’s Hospital of Philadelphia, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Blood, adding:
“I’m excited to share after a very long wait in my career finally I got a chance to contribute in ongoing research in our lab.
Our research has been published in Blood Journal, one of the world’s most prestigious journals in hematology.”
Title: Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorder
Authors: Conroy O Field, Amrita Sarkar, Khalil Bdeir, Hyunjun Kim, Santosh K Yadav, Jenna Oberg, Guohua Zhou, Steven Jiang, Manas Gumedelli, Keith R McCrae, Gowthami M Arepally, Jerome Rollin, Yves Gruel, Thomas L Ortel, M Anna Kowalska, Douglas B Cines, Kandace Gollomp, Lubica Rauova, Mortimer Poncz
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 3, 2026, 14:55Rabiah Alnoshan: The Importance of Pulse Examination in Acute Limb Ischemia
-
Jul 3, 2026, 14:44Carrie Gillies: Personal Experience Reinforces the Need for Timely DVT Diagnosis
-
Jul 3, 2026, 14:30Munazza Sikandar: Comparing Figure-of-Eight Sutures and Manual Compression for Safer Post-Ablation Care
-
Jul 3, 2026, 14:20Stefano Navarro: Partial GPVI Downregulation Shows Promise for Safer Antithrombotic Therapy
-
Jul 3, 2026, 13:31Javed Anees: TIA is a Medical Emergency – Not a Benign Warning
-
Jul 3, 2026, 12:46Heghine Khachatryan: 2026 AHA Guideline on the Management of CKM Syndrome
-
Jul 3, 2026, 12:32Shadi Tabibian: Beyond Bleeding – Women Living with von Willebrand Disease
-
Jul 3, 2026, 09:33Abdul Mannan: Not All Type 1 VWD Starts in the VWF Gene
-
Jul 3, 2026, 09:18Aryabhatta Sadhu: Sickle Cell Crisis – When Diagnostics Should Change Therapy